Apixaban (Eliquis)

apixaban · Bristol Myers Squibb and Pfizer

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Apixaban (Eliquis), covering 2025-06-18 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation [Phase 3]